I didn't know that cancer cells could manipulate glycans to escape the immune system. Fascinating field emerging right now in #biotech. #biosky #chemsky 🧪

Time for a recap of what happened in #biotech this year. #biosky #chemsky

Share the love with your #biotech nerds friends | #biosky #chemsky

#biotech #biosky 🧪

For people who are into #SciComm, this could be interesting

#biotech #biosky www.labiotech.eu/trends-news/...

The FDA has approved BridgeBio's rare heart disease drug, notably including mortality on the label. BridgeBio will brand the drug as Attruby, and it will cost about $245K per year. $BBIO endpts.com/fda-approves...

One way to track the # of patients treated w #CARTCell #immunotherapy is by sales, now on a $5 billion/year pace. h/t Bertrand Delsuc

Is this of interest to you #biosky #compsky #chemsky 🧪?

‘A place of joy’: why scientists are joining the rush to Bluesky For me, it certainly feels good to be here! @natureportfolio.bsky.social @bsky.app www.nature.com/articles/d41...

hi #bluesky, in case someone is interested in completely deleting their presence on the old site, you can use this tool for free: redact.dev It works wonderfully!

A good overview of where gene therapy is being applied #biotech 🧪

Interesting news, from a Labiotech alumni reporter

The trending two-in-one approach in #biotech 🧪

Something we've been working on this week at Labiotech: www.labiotech.eu/in-depth/jon... #biotech

Women's Health Company Freya Biosciences Announces Key $10.4 Million Strategic Investment from Gates Foundation to extend series A to $50M. www.prnewswire.com/news-release...

Hi #Bluesky 👋 I'll be sharing #biotech links here. Apparently there's still a platform on the web that cares about links (and journalism).